Open Therapeutics

We are a young, fast-growing company employing an international and multidisciplinary team of data and IT specialists who share the same mission: to enable open science. Our vision is to break down these silos, since having more data available speeds up research and creates more value for better health. We are dedicated to science and enabling it to have a positive impact on people’s lives, to our clients who enable us to work on open-source solutions, to the open source communities in which we participate and to our people who are in turn dedicated to The Hyve. We are always on the lookout for talented and dedicated individuals to join our mission of enabling open science. We are glad to have been introduced to the OHDSI real-world data platform and networks by the experts of The Hyve.". Sharing this data with fellow scientists is a real challenge. We believe that innovation can come from anywhere and it is important to keep an open mind and embrace novel ideas. As The Hyve, we always keep an eye out for new open-source tools, which can come from universities, pharma companies, research collaborations and various funding initiatives.

We provide our clients with the information and tools they need to make informed decisions. We are committed to building a culture that fosters innovation, empowers our employees, and the advancement of life science solutions for patients around the world. At Topia Life Sciences, we are passionate about improving health outcomes for people around the world.” – Kamlesh Patel, Founder. As a leading innovator in the industry, we have a strong pipeline of more than 20 products and services that span across three platforms: drug discovery, MedTech, and pharma intelligence. At Topia Life Sciences, we are passionate about improving health outcomes for people around the world. Our portfolio of products is designed to meet the evolving needs of healthcare. Pushpendra Singh Sisodia is the program leader for Topia Life Sciences’ Drug Discovery platform. Debanjan Parbat is an experienced researcher in the higher education industry with a focus on exploring IoT and AI in healthcare technology.

We provide our clients with the information and tools they need to make informed decisions. We are committed to building a culture that fosters innovation, empowers our employees, and the advancement of life science solutions for patients around the world. At Topia Life Sciences, we are passionate about improving health outcomes for people around the world.” – Kamlesh Patel, Founder. As a leading innovator in the industry, we have a strong pipeline of more than 20 products and services that span across three platforms: drug discovery, MedTech, and pharma intelligence. At Topia Life Sciences, we are passionate about improving health outcomes for people around the world. Our portfolio of products is designed to meet the evolving needs of healthcare. Pushpendra Singh Sisodia is the program leader for Topia Life Sciences’ Drug Discovery platform. Debanjan Parbat is an experienced researcher in the higher education industry with a focus on exploring IoT and AI in healthcare technology.

We are proud to have been a part of the commendable struggle to utilize the latest advancement in nucleic acid technology for the development of protein, gene, cell, and exosomes therapies. We are passionate scientists who aim to help you in the dimensions of technology, analytical methods, cell culture, purification, and drug formulation development. We are skilled in offering comprehensive technical support for regulatory processes by supporting you with content creation and content approval in a fast, reliable, and cost-effective way. With TechnoPharmaSphere, developing and manufacturing high-value medicines is enlightening and reliable. TechnoPharmaSphere Is Passionate About Helping You To Meet Your Business Goals And Accelerate Medicine Development For Patients Around The World. At TechnoPharmaSphere, we collaborate with your teams in research, development, and manufacturing to effectively deliver enhanced biopharm medicines. Our goal is to help produce clinical and market grade material for the manufacturing of quality medicines. We are a focused and flexible solutions provider that is dedicated to delivering innovative and cost-effective solutions and for better outcomes.

We are a research lab at the School of Pharmacy at the University of Waterloo that is interested in gene therapy and genetic engineering. Theraphage has worked with industry leaders and partnered with other researchers from the University of Waterloo to develop a COVID-19 vaccine that can be administered intranasally. Theraphage Lab is a diverse and interdisciplinary group of students, professors and industry leaders.

A Private But Unique Laboratory, we care for animals and humans. MyoPharm is a Canada-based company that strives to contribute to pioneering therapies by mimicking the unparalleled human physiology by the Multi-Organ-On-Chip technology platform. MyoPharm mission is to help the drug discovery pipeline through multi-organ, Microphysiological devices that supply pharmaceutical, biotechnology, and health industries which provide an entirely new approach to predicting disease mechanisms, ADME profiles, and drug efficacy in vitro, replacing laboratory animal tests and reducing the drug screening process’s costs and time. Our technology enables high-resolution, real- time imaging and in vitro analysis of biochemical, genetic and metabolic activities of living cells in a functional tissue and organ context. Our mission is to help the drug discovery pipeline through multi-organ, microphysiological devices that supply pharmaceutical, biotechnology, and health industries.